Oncolytics plans FDA talks for pancreatic cancer drug trial
Go back to Oncolytics plans FDA talks for pancreatic cancer drug trial| Bank of Commerce (NASDAQ: ONC) | Delayed: 378.25 +9.09 (2.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $369.16 | 52 Week High | $0.35 | |||
| Open | $375.00 | 52 Week Low | $0.35 | |||
| Day High | $379.48 | P/E | N/A | |||
| Day Low | $374.37 | EPS | $0.00 | |||
| Volume | 95,712 | |||||
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.82 +0.02 (2.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.80 | 52 Week High | $1.37 | |||
| Open | $0.80 | 52 Week Low | $0.24 | |||
| Day High | $0.82 | P/E | N/A | |||
| Day Low | $0.80 | EPS | $0.00 | |||
| Volume | 181,760 | |||||
